The global Nephrology Drugs Market is poised for substantial growth over the forecast period, driven by increasing prevalence of chronic kidney disease (CKD), technological advancements, and rising awareness regarding renal health. According to industry analysts, the market is projected to witness robust expansion, supported by both innovation and growing demand for effective treatment solutions.
Market Introduction